Skip to main content

Table 2 Baseline clinical features of the participants according to serum uric acid level in women

From: The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study

 

SUA levels (μmol/L)

P value

<230

230 ~ 270

270 ~ 310

310 ~ 360

>360

(n = 1359)

(n = 1325)

(n = 1436)

(n = 1389)

(n = 1642)

Age(years)

64.9(10.05)

65.1(9.70)

65.5(9.67)

66.2(9.76)

68.5(9.91)

<0.001

Age ≥ 65 (%)

680(50.0 %)

673(50.8 %)

755(52.6 %)

766(55.1 %)

1058(64.4 %)

<0.001

Current smoker (%)

20(1.5 %)

22(1.7 %)

35(2.4 %)

29(2.1 %)

19(1.2 %)

0.142

Alcohol consumption (%)

7(0.5 %)

7(0.5 %)

13(0.9 %)

7(0.5 %)

9(0.5 %)

0.602

Sedentary lifestyle (%)

228(16.8 %)

233(17.6 %)

257(17.9 %)

279(20.1 %)

336(20.5 %)

0.039

Family history of premature CVD (%)

108(7.9 %)

112(8.5 %)

135(9.4 %)

137(9.9 %)

176(10.7 %)

0.075

Height (cm)

158.1(5.43)

158.3(5.34)

158.3(5.30)

158.1(5.37)

157.7(5.62)

0.045

Weight (kg)

59.92(9.58)

60.64(9.19)

61.36(9.12)

61.85(9.78)

62.52(10.06)

<0.001

BMI (kg/m2)

23.92(3.34)

24.19(3.31)

24.46(3.20)

24.72(3.53)

25.09(3.58)

<0.001

WC (cm)

83.34(10.21)

83.69(10.15)

84.36(10.18)

84.62(10.79)

86.38(11.34)

<0.001

SBP (mmHg)

130.1(16.57)

130.0(15.63)

130.2(16.11)

130.5(16.27)

132.2(16.53)

<0.001

DBP (mmHg)

77.1(9.42)

77.4(9.43)

77.0(9.61)

77.1(10.03)

77.1(9.88)

0.889

FPG (mmol/L)a

6.62(2.88)

6.35(2.42)

6.21 (2.05)

6.35 (2.25)

6.32 (2.22)

0.007

TC (mmol/L)

4.80 (1.14)

4.83(1.21)

4.85(1.23)

4.78(1.18)

4.79(1.20)

0.504

LDL-C (mmol/L)

2.75 (0.96)

2.76(0.97)

2.76(1.02)

2.76(1.02)

2.76(1.04)

0.964

HDL-C (mmol/L)

1.45(0.39)

1.40(0.37)

1.36 (0.35)

1.32(0.36)

1.26(0.34)

<0.001

TG (mmol/L)

1.63 (1.22)

1.73 (1.08)

1.89 (1.48)

1.98 (1.39)

2.20 (1.55)

<0.001

NonHDL-C (mmol/L)

3.36(1.10)

3.43(1.16)

3.48 (1.20)

3.46(1.13)

3.53 (1.16)

0.001

Diabetes mellitus (%)

509(37.5 %)

443(33.4 %)

485(33.8 %)

521(37.5 %)

669(40.7 %)

<0.001

Hypertension (%)

802(59.0 %)

816(61.6 %)

955(66.5 %)

994(71.6 %)

1270(77.3 %)

<0.001

CHD (%)

389(28.6 %)

411(31.0 %)

473(32.9 %)

496(35.7 %)

661(40.3 %)

<0.001

Cerebrovascular disease (%)

214(15.7 %)

202(15.2 %)

207(14.4 %)

196(14.1 %)

265(16.1 %)

0.493

HF (%)

37(2.7 %)

47(3.5 %)

52(3.6 %)

61(4.4 %)

123(7.5 %)

<0.001

Peripheral arterial disease (%)

8(0.6 %)

9(0.7 %)

19(1.3 %)

15(1.1 %)

26(1.6 %)

0.044

Antihypertention agents (%)

740(54.5 %)

757(57.1 %)

902(62.8 %)

937(67.5 %)

1213(73.9 %)

<0.001

Diuretic agents (%)

44(3.2 %)

59(4.5 %)

78(5.4 %)

80(5.8 %)

159(9.7 %)

<0.001

Antiplatelet agents (%)

769(56.6 %)

765(57.7 %)

861(60.0 %)

868(62.5 %)

1117(68.0 %)

<0.001

  1. aAmong 7151 women, 4653 subjects were documented the FBG. (852 for Q1, 843 for Q2, 933 for Q3, 911 for Q4, 1114 for Q5)
  2. Abbreviations: SUA serum uric acid, CVD cardiovascular disease, WC waist circumference, CHD coronary artery disease, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, FPG fasting plasma glucose, HF heart failure, BMI body mass index
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us